STING1 and chronic kidney disease: Chronic kidney disease (CKD)-induced oxidative stress culminates in mitochondrial damage to trigger cGAS-STING activation and IFN production in vascular smooth muscle cells (VSMCs), increasing atherosclerotic plaque vulnerability (Bi et al. 2021).